(Q37935496)

English

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

scientific article published on April 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

R E Merchant

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

M D Ellison

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

H F Young

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

1 April 1990

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

173-188

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Natural killer-like activity in human cultured lymphoid cells propagated in the presence of interleukin-2: acquired resistance to prostaglandin E2- or dexamethasone-mediated suppression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ARTERIAL PCO2 AND CEREBRAL HEMODYNAMICS

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroids inhibit the generation of lymphokine-activated killer activity in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary clinical trial of immunotherapy for malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIH conference. Immunomodulators in clinical medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of patients with glioma: fact, fancy, and future

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral LAK cell and interleukin-2 therapy of human gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large granular lymphocytes are central cells in the interleukin-2-dependent differentiation pathway of natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 augments natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term culture of tumour-specific cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local and systemic effects during interleukin-2 therapy of mouse mammary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bovine aorta endothelial cell incubation with interleukin 2: morphological changes correlate with enhanced vascular permeability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of human gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurophysiological changes in the brain following central administration of immunomodulatory factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebral vasomotor responses after recombinant interleukin 2 infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotaxic implantation of dispersed cell suspensions into brain. A systematic appraisal of cell placement and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin-2 inhibits growth of human tumor xenografts in congenitally athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of porcine natural killer (NK) cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity of human recombinant interleukin-2 in rats. Pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytic infiltration in gliomas: evidence of possible host resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visualization of cytokine and virus receptors common to the immune and central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reoperation in the treatment of recurrent intracranial malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of endothelial cell prostacyclin formation by interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The differential inhibitory effects exerted by cyclosporine and hydrocortisone on the activation of human cytotoxic lymphocytes by recombinant interleukin-2 versus allospecific CTL

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological aspects of intrinsic glial tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokines and the brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro migration of human large granular lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunology of gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of oligodendroglial proliferation and maturation by interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human vascular smooth muscle cells. Target for and source of tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotactic effect of human recombinant interleukin 2 on mouse activated large granular lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of cytokines in T and B cell mediated immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy using local interleukin 2 administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytic infiltration in long-survival glioblastomas: Possible host's resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sterile abscesses in glioma patients treated by intraparenchymal injection of lymphokine-activated killer cells and recombinant interleukin-2: case reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with malignant brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage immunotherapy of malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of interleukin-2 on the blood-brain barrier in the 9L gliosarcoma rat model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2193121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00177842

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37935496&oldid=2201090262"